Atrial fibrillation (AF) remains a growing problem in the United States and worldwide,
imposing a high individual and health system burden, including increased resource …

There is a growing appreciation for differences in epidemiology, treatment, and outcomes of
cardiovascular conditions by sex. Historically, cardiovascular clinical trials have under …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Electrical disturbances, such as atrial fibrillation (AF), dyssynchrony, tachycardia, and
premature ventricular contractions (PVCs), are present in most patients with heart failure …

Aims There are conflicting data as to the impact of procedural volume on outcomes with
specific reference to the incidence of major complications after catheter ablation for atrial …

Aim The impact of sex differences on the clinical outcomes of radiofrequency catheter
ablation (RFCA) of atrial fibrillation (AF) is controversial. We investigated the sex differences …

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is
associated with impaired health-related quality of life (HRQoL), high symptom severity, and …

Sex and gender are important factors influencing the epidemiology and outcomes of
cardiovascular care in various cardiac arrhythmias. Observed sex-related differences are …

Introduction Concerns exist of women underrepresentation in atrial fibrillation (AF) studies,
potentially limiting the generalisability of study findings to women with AF. We assessed the …

Background There is sufficient evidence that women with atrial fibrillation (AF) have a
greater symptom burden than men with AF and are more likely to experience recurrence …